This session discusses the use of monoclonal antibodies for COVID-19 in long-term care facilities.*
*Participants of this session should note that material covered in the session includes rapidly changing and ongoing research. While the information presented was accurate on the day it was recorded, participants should make sure they acquaint themselves with any updates made to best practices and new evidence.
Continuing Education Instructions and Disclosure Information:
Contact hours available until 3/6/2023.
Requirements for Successful Completion: Complete the learning activity in its entirety and complete the online NCPD evaluation. You will be able to print your NCPD certificate at any time after you complete the evaluation.
Faculty, Planners, and Speakers Conflict of Interest Disclosure:
Conferences Planning Committee Disclosures: No planning committee member discloses any actual or potential conflict of interest.
Speakers Conflict of Interest Disclosure: Laurent Adler discloses that he receives financial/other material support as an employee of Optum.
Commercial Support and Sponsorship: No commercial support or sponsorship declared.
Accreditation Statement: This educational activity is jointly provided by Anthony J. Jannetti, Inc. (AJJ) and the Gerontological Advanced Practice Nurses Association (GAPNA).
Anthony J Jannetti, Inc. is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
Anthony J. Jannetti, Inc. is a provider approved by the California Board of Registered Nursing, Provider Number CEP5387.
Learning Outcome: After completing this learning activity, the participant will be able to describe the use of monoclonal antibodies in the care of older adult patients with COVID-19 in long-term care facilities.